Novel Therapies for EGFR Exon 20 Insertions and ALK-Positive NSCLC: Developments and Implications

Are you up to date on managing patients with EGFR exon 20 insertion-mutated and ALK-positive NSCLC? Credit available for this activity expires: 4/26/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972727?src=mkm_podcast_addon_972727